Unknown

Dataset Information

0

YAP/TAZ Signaling and Resistance to Cancer Therapy.


ABSTRACT: Drug resistance is a major challenge in cancer treatment. Emerging evidence indicates that deregulation of YAP/TAZ signaling may be a major mechanism of intrinsic and acquired resistance to various targeted and chemotherapies. Moreover, YAP/TAZ-mediated expression of PD-L1 and multiple cytokines is pivotal for tumor immune evasion. While direct inhibitors of YAP/TAZ are still under development, FDA-approved drugs that indirectly block YAP/TAZ activation or critical downstream targets of YAP/TAZ have shown promise in the clinic in reducing therapy resistance. Finally, BET inhibitors, which reportedly block YAP/TAZ-mediated transcription, present another potential venue to overcome YAP/TAZ-induced drug resistance.

SUBMITTER: Nguyen CDK 

PROVIDER: S-EPMC6557283 | biostudies-literature | 2019 May

REPOSITORIES: biostudies-literature

altmetric image

Publications

YAP/TAZ Signaling and Resistance to Cancer Therapy.

Nguyen Chan D K CDK   Yi Chunling C  

Trends in cancer 20190327 5


Drug resistance is a major challenge in cancer treatment. Emerging evidence indicates that deregulation of YAP/TAZ signaling may be a major mechanism of intrinsic and acquired resistance to various targeted and chemotherapies. Moreover, YAP/TAZ-mediated expression of PD-L1 and multiple cytokines is pivotal for tumor immune evasion. While direct inhibitors of YAP/TAZ are still under development, FDA-approved drugs that indirectly block YAP/TAZ activation or critical downstream targets of YAP/TAZ  ...[more]

Similar Datasets

| S-EPMC4538707 | biostudies-literature
| S-SCDT-10_1038-S44318-024-00085-6 | biostudies-other
| S-EPMC7069086 | biostudies-literature
| S-EPMC10412783 | biostudies-literature
| S-EPMC6755808 | biostudies-literature
| S-EPMC5642684 | biostudies-literature
| S-EPMC7890025 | biostudies-literature
| S-EPMC10293011 | biostudies-literature
| S-EPMC6115388 | biostudies-literature
| S-EPMC8241934 | biostudies-literature